Archived App (Last seen on 26 Feb 2026)
This is an archived listing of the app previously available on the App Store.
This app is designed for participants in a clinical study to report and manage Fibromyalgia symptoms. It is intended for use with a specific investigational medical device and requires supervision from study staff. Users should consult a doctor alongside using this application for medical decisions.
1.0.1
September 2, 2024
Bug fixes
TCH-101 is an application designed for participants in a clinical study to report and manage their Fibromyalgia symptoms. It is intended for use in conjunction with an investigational medical device.
TCH-101 is exclusively for participants of the TCH-101 clinical study in the US and Israel who have passed pre-clinical screening and are using the associated medical device.
Yes, the disclaimer explicitly states that users should seek a doctor's advice in addition to using TCH-101 and before making any medical decisions. It is intended for use under the advisement of study staff.
No, TCH-101 is not available to the general public. It is strictly for participants in the TCH-101 clinical study and requires use with a specific investigational medical device.
TCH-101 supports iPhone and iPod devices. It is not currently listed as available for Android or other platforms.
The latest version of TCH-101 is 1.0.1, which was last updated on September 2, 2024. This indicates a recent update for the application.
TCH-101 has an age rating of 17+. This suggests content that may not be suitable for younger individuals.
No, TCH-101 does not contain advertisements. The app is free to download and use for its intended study participants.
